BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16475173)

  • 1. Repression of HIP/RPL29 expression induces differentiation in colon cancer cells.
    Liu JJ; Huang BH; Zhang J; Carson DD; Hooi SC
    J Cell Physiol; 2006 May; 207(2):287-92. PubMed ID: 16475173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the cytologic distribution of heparin/heparan sulfate interacting protein/ribosomal protein L29 (HIP/RPL29) during in vivo and in vitro mouse mammary epithelial cell expression and differentiation.
    Kirn-Safran CB; Julian J; Fongemie JE; Hoke DE; Czymmek KJ; Carson DD
    Dev Dyn; 2002 Jan; 223(1):70-84. PubMed ID: 11803571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIP/RPL29 down-regulation accompanies terminal chondrocyte differentiation.
    Miller SA; Brown AJ; Farach-Carson MC; Kirn-Safran CB
    Differentiation; 2003 Aug; 71(6):322-36. PubMed ID: 12919102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin/heparan sulfate interacting protein plays a role in apoptosis induced by anticancer drugs.
    Liu JJ; Zhang J; Ramanan S; Julian J; Carson DD; Hooi SC
    Carcinogenesis; 2004 Jun; 25(6):873-9. PubMed ID: 14729579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of p21cip1/waf1 overexpression on growth, apoptosis and differentiation in human colon carcinoma cells.
    Izawa H; Yamamoto H; Damdinsuren B; Ikeda K; Tsujie M; Suzuki R; Kitani K; Seki Y; Hayashi T; Takemasa I; Ikeda M; Ohue M; Sekimoto M; Monden T; Monden M
    Int J Oncol; 2005 Jul; 27(1):69-76. PubMed ID: 15942645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular differentiation-induced attenuation of LPS response in HT-29 cells is related to the down-regulation of TLR4 expression.
    Lee SK; Il Kim T; Kim YK; Choi CH; Yang KM; Chae B; Kim WH
    Biochem Biophys Res Commun; 2005 Nov; 337(2):457-63. PubMed ID: 16202385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells.
    Moh MC; Zhang T; Lee LH; Shen S
    Carcinogenesis; 2008 Dec; 29(12):2298-305. PubMed ID: 18845560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells.
    Archer SY; Johnson J; Kim HJ; Ma Q; Mou H; Daesety V; Meng S; Hodin RA
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G696-703. PubMed ID: 16160080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinol decreases beta-catenin protein levels in retinoic acid-resistant colon cancer cell lines.
    Dillard AC; Lane MA
    Mol Carcinog; 2007 Apr; 46(4):315-29. PubMed ID: 17219422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrate regulates E-cadherin transcription, isoform expression and intracellular position in colon cancer cells.
    Barshishat M; Polak-Charcon S; Schwartz B
    Br J Cancer; 2000 Jan; 82(1):195-203. PubMed ID: 10638989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.
    Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M
    Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells.
    Wang Q; Sun Z; Yang HS
    Oncogene; 2008 Mar; 27(11):1527-35. PubMed ID: 17828298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
    Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
    Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitors induce cell death selectively in cells that harbor activated kRasV12: The role of signal transducers and activators of transcription 1 and p21.
    Klampfer L; Huang J; Shirasawa S; Sasazuki T; Augenlicht L
    Cancer Res; 2007 Sep; 67(18):8477-85. PubMed ID: 17875686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of NF-kappaB activity on beta-catenin/Tcf pathway in various cancer cells.
    Cho HH; Song JS; Yu JM; Yu SS; Choi SJ; Kim DH; Jung JS
    FEBS Lett; 2008 Mar; 582(5):616-22. PubMed ID: 18242184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hath1, down-regulated in colon adenocarcinomas, inhibits proliferation and tumorigenesis of colon cancer cells.
    Leow CC; Romero MS; Ross S; Polakis P; Gao WQ
    Cancer Res; 2004 Sep; 64(17):6050-7. PubMed ID: 15342386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of expression of lineage-specific markers during the in vitro-induced differentiation of HT29 colon carcinoma cells.
    Velcich A; Palumbo L; Jarry A; Laboisse C; Racevskis J; Augenlicht L
    Cell Growth Differ; 1995 Jun; 6(6):749-57. PubMed ID: 7669730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential role of diphenyleneiodonium, a flavoenzyme inhibitor, on p53-dependent and -independent cell cycle progression.
    Song JD; Kim KM; Kim KH; Kim CD; Kim JM; Yoo YH; Park YC
    Int J Oncol; 2008 Dec; 33(6):1299-306. PubMed ID: 19020764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.